← Back to directory

Nebojša Lalić

Researcher Next ID · RN-015339

Researcher · Medicine

University of Belgrade

, Serbia

Not currently recruitingFunding unknown
Works count
263
Citation count
11,355
H-index
46
i10-index
105

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Diabetes Management and Research
Diabetes Treatment and Management
Diabetes, Cardiovascular Risks, and Lipoproteins
Diabetes and associated disorders
Pancreatic function and diabetes

Publications

  • Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

    European Journal of Preventive Cardiology · 2019 · 10.1177/2047487318825350

  • PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

    Diabetes Care · 2019 · 10.2337/dc19-0749

  • 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    The Lancet · 2017 · 10.1016/s0140-6736(17)30069-7

  • Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

    Diabetologia · 2009 · 10.1007/s00125-009-1472-y

  • Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

    Journal of Clinical Investigation · 1997 · 10.1172/jci119628

Current projects

    No projects listed.